Please assess the completion status of the following clinical trial:

Trial Title: Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Patients with RRP which sign the informed consent form with both parts of the study will be enrolled.~Exclusion Criteria:~Patients who experience severe side effects of vaccination after the first or second dose will not be vaccinated with the third dose and they will be excluded from the study. Patients who will not receive all three doses within one year and 30 days will be also excluded.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vaccine Silgard (Type: EXPERIMENTAL): vaccination with tetravalent antiviral vaccine, 3 doses

Based on this trial design, predict the completion outcome and termination type (if applicable).